Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Frystyk

Showing results (161-170 of 292) with videos related to

Pageof 30
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 6, 2018
Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissueRikke Hjortebjerg, Darlene E Berryman, Ross Comisford, et al.
Clinical Endocrinology|December 11, 2008
Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adultsMorten B Krag, Lars M Rasmussen, Troels K Hansen, et al.
Diabetes Care|May 28, 2005
Serum adiponectin is increased in type 1 diabetic patients with nephropathyMarkku Saraheimo, Carol Forsblom, Johan Fagerudd, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2005
Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonistJens Otto Lunde Jørgensen, Ulla Feldt-Rasmussen, Jan Frystyk, et al.
The American Journal of Cardiology|November 22, 2011
Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosisRasmus Mogelvang, Sune H Pedersen, Allan Flyvbjerg, et al.
Journal of Diabetes and Its Complications|August 24, 2013
Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetesAnders Jorsal, Emilie Hein Petersen, Lise Tarnow, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormoneHelene Nørrelund, K Sreekumaran Nair, Steen Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2020
Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease PatientsRikke Hjortebjerg, Lars Melholt Rasmussen, Mette Faurholdt Gude, et al.
European Journal of Preventive Cardiology|November 23, 2013
Adiponectin, type 2 diabetes and cardiovascular riskSøren Lindberg, Jan Skov Jensen, Mette Bjerre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2011
Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosisMichael F Nielsen, Niels K Aagaard, Thorbjørn Grøfte, et al.
Pageof 30

Showing results (161-170 of 292) with videos related to

Sort By:
Pageof 30
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 6, 2018
Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissueRikke Hjortebjerg, Darlene E Berryman, Ross Comisford, et al.
Clinical Endocrinology|December 11, 2008
Peroxisome proliferator-activated receptor gamma (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adultsMorten B Krag, Lars M Rasmussen, Troels K Hansen, et al.
Diabetes Care|May 28, 2005
Serum adiponectin is increased in type 1 diabetic patients with nephropathyMarkku Saraheimo, Carol Forsblom, Johan Fagerudd, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2005
Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonistJens Otto Lunde Jørgensen, Ulla Feldt-Rasmussen, Jan Frystyk, et al.
The American Journal of Cardiology|November 22, 2011
Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosisRasmus Mogelvang, Sune H Pedersen, Allan Flyvbjerg, et al.
Journal of Diabetes and Its Complications|August 24, 2013
Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetesAnders Jorsal, Emilie Hein Petersen, Lise Tarnow, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormoneHelene Nørrelund, K Sreekumaran Nair, Steen Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2020
Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease PatientsRikke Hjortebjerg, Lars Melholt Rasmussen, Mette Faurholdt Gude, et al.
European Journal of Preventive Cardiology|November 23, 2013
Adiponectin, type 2 diabetes and cardiovascular riskSøren Lindberg, Jan Skov Jensen, Mette Bjerre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2011
Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosisMichael F Nielsen, Niels K Aagaard, Thorbjørn Grøfte, et al.
Pageof 30